FdaApplication
ANDA 217183
Identifiers
- fda_app_no: ANDA217183
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2024-03-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LITHIUM CITRATE | LITHIUM CITRATE | EQ 300MG CARBONATE/5ML | SYRUP;ORAL |
1 product